Intersting thoughts

Search

Member
Joined
Dec 13, 2007
Messages
13,108
Tokens
new-jt-banner-newsletter.png

Global Market Comments
February 1, 2021
Fiat Lux

Featured Trade:
(MARKET OUTLOOK FOR THE WEEK AHEAD, or GAMBLERS
HAVE ENTERED THE MARKET),
($INDU), (TSLA), (TLT), (BA), (JPM), (MS), (GME),
(STBX), (GE), (MRNA)

mti-pos-38.jpg



The Market Outlook for the Week Ahead, or Gamblers Have Entered the Market

At long last, the 10% correction I have been predicting is happening. No, it wasn’t caused by the usual reasons, like a bad economic data point, an earnings disappointment, or a geopolitical event.
The market delivered the worst week since October because gamblers have entered the stock market. Perish the thought!

It turns out that if a million kids buy ten shares each of a $4 stock, they can wipe out even the largest hedge funds on their short positions. It also turns out they can wipe out their brokers, with infinite capital calls triggered by massive order flows.

If Chicago’s Citadel had not stepped in with a $1 billion bailout, Robin Hood would have gone under last week. Citadel buys Robin Hood’s order flow and is their largest customer. That’s where systemic risk enters the picture.

And it’s not like there was really any systemic risk. Markets have an inordinate fear of the unknown, and no one has ever seen a bunch of kids in a chat room like Redditt wipe out major hedge funds.

Fortunately, there are only a dozen small illiquid stocks that could be subject to such ‘buyers raids”. So, the spillover to the main market is very limited, probably no more than a week or two.

And the regulations to reign in such a practice are already in place. Whenever a broker gets more business than it can handle, it will simply shut it down. Robin Hood did that on Friday when it has limited purchases in 20 stocks to a single share, including Starbucks (STBX), Moderna (MRNA), and General Electric (GE).

What all this does is set up an excellent buying opportunity for you and me, of which there have been precious few in recent months. By ramping up the Volatility Index to $38, it is almost impossible to lose money on front month call options spreads. We are the real winners of the (GME) squeeze.

Stocks would have to fall another 10%-20% on top of existing 10%-20% declines, and that is not going to happen in 13 trading days to the February 19 options expiration with $20 trillion about to hit the economy and the stock markets. That breaks down to $10 trillion in stimulus and $10 trillion worth of global quantitative easing.

My own long, hard-won experience is that a (VIX) at $38 earns you about 20% a month in profits. Options prices are so elevated that scoring winners now is like shooting fish in a barrel. So, join the party as fast as you can.

On Friday, I was taking profits on exiting positions and shipping out new trade alerts in the best quality names as fast as I could write them. Where is that easy, laid back retirement I was hoping for!

Keep at the barbell portfolio. The big tech names are finishing up a six-month sideways “time” corrections. Their earnings are catching up with valuations at a prolific rate. The domestic recovery names have just given back 10%-20% and are ripe for another leg up. All of these are good candidates for 2023 options LEAPS.

After all, if an insurrection and the sacking of the capitol can’t take the market down more than 1%, GameStop (GME) is certainly not going to take it down more than 10%.

GameStop (GME) posted record volatility, up from $4 a month ago to $483. Even the biggest hedge funds can’t stand up to a million kids buying ten shares each at market. All single name shorts in the market are getting covered by hedge funds in fear of getting “Gamestopped”, producing a 700-point Dow rally.

Several brokers banned trading in the name and the SEC is all over this like a wet blanket. Trading is halted due to an excess of sell orders. The problem is that funds are selling real stocks to cover the losses we own, like JP Morgan (JPM) and Tesla (TSLA) and short (TLT).

In the meantime, the action has moved over the American Airlines (AA), which has soared by 50%. AMC Entertainment Holdings (AMC) saw a 400% pop, but I haven’t seen anyone rushing back into theaters to watch Wonder Woman. Blame Jay Powell for flooding the financial system with mountains of cash seeking a home. There is so much money in circulation that traders are invented asset classes to put it into. This can’t last. Buy the dip.

Here are the best short squeeze targets with the greatest outstanding short interests. GameStop (GME) tops the list with an eye-popping 139% short interest, followed by Bed Bath & Beyond (BBBY) (67%) and Ligand Pharmaceutical (LGND) (64%). National Beverage (FIZZ), The Macerich Company (MAC), and Fubo TV (FUBO) bring up the rear. These are all failed companies in some form or another, which is why hedge funds had such large short positions.

New Home Sales disappointed in December, up only 1.6% to 842,000 units. This is on a signed contract basis only. Affordability is the big issue caused by high prices. Who buys a house at Christmas anyway?

Case Shiller soared by 9.5% in November, the fastest home price appreciation in history. Phoenix (13.8%), Seattle (12.7%), and San Diego (12.3) were the big movers. Blame a long-term structural housing shortage, a huge demographic push from Millennials, near-zero interest rates, and a flight from the cities to larger suburban homes. The Pandemic is keeping millions of homes off the market.

US GDP may reach pre-pandemic high by end of 2021, it the vaccine gets distributed to every corner of the nation and aggressive stimulus packages pass congress. Growth should come in at a minimum of 5% or higher this year, wiping out last year’s disaster. Keeping interest rates near zero will be a big help, as Treasury Secretary Yellen is determined to do. China and India are already there.

Share Buybacks have returned, the catnip of share prices. Q4 saw a jump to $116 billion from $102 billion in Q2, and this year, banks now have free reign to buy back their own shares. That’s still below the $182 billion seen in Q4 2019. It can only mean that share prices are rising further.

California lifts stay-at-home regulations, enabling restaurants to open after a nearly two-month shutdown. It’s the first ray of hope that the pandemic will end by summer. It will if Biden hits his 1.5 million vaccinations a day target.

Tesla posts sixth consecutive profit quarter, taking the stock down $60 in the aftermarket momentarily on a classic “buy the rumor, sell the news” move. The once cash-starved company now has an eye-popping $19.4 billion in reserves. Revenues reached a massive $10.7 billion, better than expected. Gross margins reached 19.2%. Looking for 50% annual growth for several years. Shanghai, Berlin, and Austin will make their first deliveries this year. Cash flow is at $19.4 billion, enough to build six more factories. No short sellers left here. It’s a perfect entry point for a LEAP. Buy the March 2023 $1,150-$1,200 call spread for a ten bagger.

Space X rocket carries 143 spacecraft into space. The Falcon 9 rocket set a new record with new satellites launched at once. Yes, you too can put 200kg into orbit for only $1 million. Many are from small tech startups selling various types of data. Elon Musk’s hobby, now worth $20 billion according to its government contracts, could be his next IPO. Don’t pass on this one!


When we come out the other side of pandemic, we will be perfectly poised to launch into my new American Golden Age, or the next Roaring Twenties. With interest rates still at zero, oil cheap, there will be no reason not to. The Dow Average will rise by 400% to 120,000 or more in the coming decade. The American coming out the other side of the pandemic will be far more efficient and profitable than the old. Dow 120,000 here we come!

My Mad Hedge Global Trading Dispatch earned a blockbuster 10.21% in January, versus a Dow Average that is now down in 2021. This is my third double-digit month in a row.

I used the market selloff to take substantial profits in my short (TLT) holdings and buy new longs in Boeing (BA) and Morgan Stanley (MS). I rolled the strikes down on my JP Morgan (JPM) long by $10.

That brings my eleven-year total return to 432.76%, some 2.15 times the S&P 500 over the same period. My 11-year average annualized return now stands at a nosebleed new high of 38.85%, a new high.

My trailing one-year return exploded to 75.28%, the highest in the 13-year history of the Mad Hedge Fund Trader. We have earned 91.43% since the March 20 2020 low.

We need to keep an eye on the number of US Coronavirus cases at 26 million and deaths at 441,000, which you can find here. We are now running at a staggering 3,800 deaths a day.

The coming week will be all about the monthly jobs data.

On Monday, February 1 at 9:45 AM EST, the Markit Manufacturing PMIfor January is out. Caterpillar (CAT) announces earnings.

On Tuesday, February 2 at 7:00 AM, Total Vehicle Sales for January are published. Alphabet (GOOG) and Amgen (AMGN) report.

On Wednesday, February 3 at 8:15 AM, the ADP Private Employment Report is published. QUALCOMM (QCOM) reports.


On Thursday, February 4 at 9:30 AM, Weekly Jobless Claims are printed. Gilead Sciences (GILD) reports.

On Friday, February 5 at 9:30 AM, the January Nonfarm Payroll Report is announced. At 2:00 PM, we learn the Baker-Hughes Rig Count.

As for me, I am often kept awake at night by painful arthritis and a collection of combat injuries and I usually spend this time thinking up new trade alerts.

However, the other night, I saw a war movie just before I went to bed, so of course, I thought about the war. This prompted me to remember the two happiest people I have met in my life.

My first job out of college was to go to Hiroshima Japan for the Atomic Energy Commission and interview survivors of the first atomic bomb 29 years after the event. There, I met Kazuko, a woman in her late forties who was attending college in Fresno, California in 1941 and spoke a quaint form of English from the period. Her parents saw the war and the internment coming, so they brought her back to Hiroshima to be safe.

Her entire family was gazing skyward when a sole B-29 bomber flew overhead. One second before the bomb exploded, a dog barked and Kazuko looked to the right. Her family was permanently blinded, and Kazuko suffered severe burns on the left side of her neck, face, and forearms. A white summer yukata protected the rest of her, reflecting the nuclear flash. Despite the horrible scarring, she was the most cheerful person I had ever met and even asked me how things were getting on in Fresno.

Then there was Frenchie, a man I played cards with at lunch at the Foreign Correspondents Club of Japan every day for ten years. A French Jew, he had been rounded up by the Gestapo and sent to the Bergen-Belson concentration camp late in the war. A faded serial number was still tattooed on his left forearm. Frenchie never won at cards. Usually, I did because I was working the probabilities in my mind all the time, but he never ceased to be cheerful no matter how much it cost him.

The happiest people I ever met were atomic bomb and holocaust survivors. I guess, if those things can’t kill, you nothing can, and you’ll never have a reason to be afraid again. That is immensely liberating.

Stay healthy.

John Thomas
CEO & Publisher
The Diary of a Mad Hedge Fund Trader

1yr-feb1.png

11yr-feb1.png

decline-gdp-feb1.png

indu-feb1.png

tlt-feb1.png

tsla-feb1.png

gme-feb1.png

slv-feb1.png

john-thomas-snow-car.png



Quote of the Day“If markets were rational, I would be washing dishes for a living,” said Oracle of Omaha Warren Buffet.

warren-buffet2.png







 

Member
Joined
Dec 13, 2007
Messages
13,108
Tokens
Up 33% today on huge volume


MNKKQ....Made the short all star list this week.
This stock still has 25% days both directions.




SHORTED STOCKS

*Last Updated: February 1, 2021

STOCKCOMPANYLAST PRICESHORT INTEREST% FLOATDAYS TO COVER% SHARES SHORT
GMEGameStop Corp$325.0061.78M226.42%2.8188.58%CHART
LGNDLigand Pharmaceuticals Inc$185.3510.01M107.56%33.0862.24%CHART
BBBYBed Bath & Beyond Inc$35.3374.89M82.41%6.2961.78%CHART
FUBOFuboTV Inc$42.2539.17M72.74%1.1357.98%CHART
MACMacerich Co$15.7078.54M85.84%18.4352.55%CHART
MNKMallinckrodt PLC$0.2542.95M51.54%11.5650.77%CHART
SKTTanger Factory Outlet Centers Inc$15.4347.25M75.26%19.2650.56%CHART
MNKKQMallinckrodt PLC$0.4741.72M50.08%10.5849.33%CHART
BGGSQBriggs & Stratton Corp$0.1619.45M76.87%4.9445.81%CHART
BGGBriggs & Stratton Corp$0.7819.45M76.87%4.9445.81%CHART
ESPREsperion Therapeutics Inc$31.4911.08M50.44%13.6142.82%CHART
CHKAQChesapeake Energy Corp$4.723.88M39.62%0.9639.62%CHART
AMCXAMC Networks Inc$49.4215.63M90.16%17.1137.89%CHART
IRBTiRobot Corp$120.1010.55M65.1%17.9337.5%CHART
PYXPyxus International Inc$0.403.39M0%5.9536.93%CHART
FTRCQFrontier Communications Corp$0.5138.3M36.78%16.4136.48%CHART
BGSB&G Foods Inc$38.0823.14M51.96%14.6436.02%CHART
PLCEChildren's Place Inc$73.475.15M64.53%8.5935.3%CHART
CLVSClovis Oncology Inc$7.9036.12M35.79%6.4234.92%CHART
PYXSQPyxus International Inc$0.153.16M0%3.8334.4%CHART
 

Member
Joined
Dec 13, 2007
Messages
13,108
Tokens
PRESENTED BY FACEBOOK Axios AMBy Mike Allen ·Feb 02, 2021❄️ Good Tuesday morning, and happy Groundhog Day! Since we just had Groundhog Year ...

⚾ One win for normality: Baseball's Opening Day will remain April 1 — and the schedule will be a full 162 games — after players rejected a plan to delay spring training by more than a month due to COVID. Play deep.

  • Today's Smart Brevity™ count: 1,166 words ... 4½ minutes.
1 big thing: Inside the craziest meeting of Trump's presidency
1612256572088.jpg
Photo illustration: Sarah Grillo/Axios. Getty Images photos: Tom Williams/CQ-Roll Call, Jabin Botsford/The Washington Post, George Frey/Bloomberg
This is a bonus episode of "Off the rails," our fly-on-the-wall series by Jonathan Swan and Zachary Basu, taking you inside the end of Donald Trump's presidency.

  • Here's one of the most detailed accounts you'll ever read of a White House meeting, short of having a camera in the room. It was one long, unhinged night a week before Christmas. An epic, profanity-soaked standoff played out, with profound implications for the nation:
Four conspiracy theorists marched into the Oval Office. It was early evening on Friday, Dec. 18 — a month after the election had been declared for Joe Biden, and four days after the Electoral College met in every state to make it official.

  • "How the hell did Sidney get in the building?" White House senior adviser Eric Herschmann grumbled from the outer Oval Office as Sidney Powell and her entourage strutted by to visit the president.
President Trump's private schedule hadn't included appointments for Powell or the others, including former national security adviser Michael Flynn and former Overstock.com CEO Patrick Byrne.

  • The hours to come would pit the insurgent conspiracists against a handful of White House lawyers and advisers determined to keep the president from giving in to temptation to invoke emergency national security powers.
  • The arguments became so heated that even Rudy Giuliani, on the phone, told everyone to calm down. One participant later recalled: "When Rudy's the voice of reason, you know the meeting's not going well."
Trump was no longer focused on any semblance of a governing agenda, instead spending his days taking phone calls and meetings from anyone armed with conspiracy theories about the election.

  • For the White House staff, it was an unending sea of garbage churned up by the bottom feeders.
Trump expressed skepticism at various points about Powell's theories, but he said: "At least she’s out there fighting."

  • At its essence, the Powell crew's argument to the president was this: We have the real information. These people — your White House staff — don't believe in the truth. They're liars and quitters. Put us in charge.
On some level, this argument was music to Trump's ears. He was desperate.

  • The Oval Office portion of the meeting had dragged on for nearly three hours, creeping beyond 9 p.m.
  • Giuliani told Trump he was going to come over to the White House. The president, having forgotten about the others on the line, hung up and cut multiple people off the call.
The entourage went upstairs to the Yellow Oval Room, Trump's living room. Staff set pigs in a blanket and little meatballs on toothpicks on the coffee table.

  • It didn't take long for the yelling to start up again.
Keep reading!

  • Listen to Jonathan Swan on Axios' new investigative podcast series, called "How it happened: Trump's last stand."
  • Read the rest of the "Off the Rails" episodes here.
2. Vaccine chaos may undermine second doses
1612262850991.jpg
Illustration: Sarah Grillo/Axios
The Biden administration isn't holding doses in reserve for people's second shots — it's shipping everything it can right away, trying to give as many people as possible at least some protection, Axios Vitals author Caitlin Owens writes.

  • Second doses will come from new supplies, although some providers and health departments are withholding second doses themselves.
Keep reading.
3. Internet blackouts skyrocket amid global unrest
2021-02-01-internet-shutdown-fallback.png
Data: Axios analysis of NetBlocks reports. Map: Andrew Witherspoon/Axios
Where there’s a coup, there will probably be an internet outage, Axios' Dave Lawler and Sara Fischer report:

  • Internet disruptions in Myanmar coincided yesterday with reports that Aung San Suu Kyi and other leaders were being rounded up by the military.
Internet blackouts are now common around the world when power hangs in the balance.

  • At least 35 countries have restricted access to the internet or social media platforms at least once since 2019, according to Netblocks, which tracks internet freedom.
  • Blockages are particularly common around elections in Africa.
  • Netblocks also reported disruptions in Russian cities during recent protests.
Keep reading.
A MESSAGE FROM FACEBOOK
It’s time to update internet regulations
imgad
The internet has changed a lot in 25 years. But the last time comprehensive internet regulations were passed was in 1996.
We support updated internet regulations to set clear guidelines for addressing today's toughest challenges.
Learn More
4. Billionaire space battle
1612261467441.jpg
Illustration: Aïda Amer/Axios
A scuffle over satellite altitudes — between Amazon and SpaceX — shows how competitions between companies today are shaping humanity's future in space, Axios Space author Miriam Kramer reports.

  • Elon Musk last week asked the FCC to allow SpaceX to lower the orbits of some satellites in its planned constellation.
  • But Amazon — which plans to launch its Project Kuiper satellites in the coming years — and other operators objected, saying the modification would interfere with their satellites.
Keep reading.

  • Sign up for Miriam Kramer's weekly newsletter, Axios Space, out later today.
5. Axios-Ipsos poll: New strains, not school spread, drive fears
2021-02-01-2218-percent-concerned-about-fallback.png
Data: Axios/Ipsos survey. Chart: Axios Visuals
Americans are deeply worried about new strains of the coronavirus, prompting some to double-mask, Axios managing editor Margaret Talev writes from the Axios/Ipsos Coronavirus Index.

  • But fears have eased substantially around sending children back to school.
Keep reading.
6. GameStop revolt exposes financial plumbing
1612261004307.jpg
Kate McKinnon interviews Pete Davidson as "the new majority shareholder of GameStop," on "Saturday Night Live" cold open. Photo: Will Heath/NBC
The Reddit trading frenzy is exposing inner workings of the financial system, bringing two middlemen to the forefront, Axios markets reporter Courtenay Brown writes.
1. Clearinghouses — the intermediary between stock buyers and sellers — are in the headlines in a way they haven't been since the 2008 financial crisis.

  • Robinhood CEO Vlad Tenev said on Clubhouse that he got a "nerve-wracking" 3:30 a.m. call from the DTCC, the clearinghouse that settles 99% of equity trades, asking him to put up $3 billion in collateral.
2. Market-makers, who pay brokerages to direct trades their way, were the subject of widespread, misleading theories.

Headline for our times ...
1612256269830.png
The Wall Street Journal

  • Keeper headline, from AP: "Wall Street's GameStop bug may have mutated; silver surges."
7. Tech giants open up about algorithms
1612264283093.gif
Illustration: Annelise Capossela/Axios
Google, Facebook, TikTok and others are starting to talk more about how their algorithms work in a bid to win trust, Axios' Sara Fischer and Margaret Harding McGill report:

  • Google published a blog post yesterday that shows users how to access more information about their search results, the day ahead of its Q4 earnings report.
  • Facebook released a post last week about how its News Feed algorithm works the day before its Q4 earnings.
  • TikTok last year, amid the threat of a ban from the Trump administration, walked reporters through a presentation on its prized algorithm.
Keep reading.
8. Transgender health startups on rise
1612262577129.jpg
Plume chief medical officer Dr. Jerrica Kirkley. Photos: Plume
Transgender health needs, long neglected by the medical establishment, could get a needed assist from tech, as a pair of startups that focus on hormone treatment and other services today announce fresh venture funding, Axios' Ina Fried reports.

  • Why it matters: Transgender and non-binary people can face enormous barriers to health care, from a scarcity of facilities that provide gender-affirming care to insurance company denials and outright discrimination.
Plume and Folx announce Series A funding rounds today.

  • Both bypass traditional insurance and provide care online.
  • Few companies focused on LGBT consumers — and transgender people in particular — have attracted venture funding.
Keep reading.
9. The sweep of history — in stamps
1612258412809.png
Graphic: Bruce Mehlman
Bruce Mehlman of Mehlman Castagnetti Rosen & Thomas is out with one of his famous decks, and this is my favorite slide. Bruce tells me:
Roughly every 60 years, Americans arrive at a crisis moment where low trust in established institutions — and widespread dismay at the state of society — catalyze disruptive, systemic change.
Play with a full deck.
10. Pandemic pauses "peak TV"
2021-02-01-scripted-series-fallback.png
Reproduced from an FX Networks Research report. Chart: Axios Visuals
The number of new original scripted series finally declined last year, after growing steadily for the past decade to over 500 new shows in 2019, Axios Media Trends author Sara Fischer writes.

  • Why it matters: Pandemic-related pauses in production have left stuck-at-home consumers antsy for more new hits. But more are on the way.
  • Keep reading.
Sign up for Sara Fischer's weekly newsletter, Axios Media Trends, out later today.
A MESSAGE FROM FACEBOOK
Internet regulations need an update
imgad
 

Member
Joined
Dec 13, 2007
Messages
13,108
Tokens
new-jt-banner-newsletter.png

[FONT=Arial, Helvetica, sans-serif]Global Market Comments
February 2, 2021
Fiat Lux
[/FONT]
[FONT=Arial, Helvetica, sans-serif]Featured Trade:[/FONT]
[FONT=Arial, Helvetica, sans-serif](MY NEWLY UPDATED LONG-TERM PORTFOLIO),
(PFE), (BMY), (AMGN), (CELG), (CRSP), (FB), (PYPL), (GOOGL), (AAPL), (AMZN), (SQ), (JPM), (BAC), (MS), (GS), (BABA), (EEM), (FXA), (FCX), (GLD), (SLV), (TLT)
[/FONT]
[FONT=Arial, Helvetica, sans-serif]
mti-pos-43.jpg
[/FONT]


My Newly Updated Long-Term Portfolio

I am really happy with the performance of the Mad Hedge Long Term Portfolio since the last update on July 21, 2020. In fact, not only did we nail the best sectors to go heavily overweight, we also completely dodged the bullets in the worst-performing ones.[FONT=Arial, Helvetica, sans-serif]For new subscribers, the Mad Hedge Long Term Portfolio is a “buy and forget” portfolio of stocks and ETFs. If trading is not your thing, these are the investments you can make, and then not touch until you start drawing down your retirement funds at age 72.

For some of you, that is not for another 50 years. For others, it was yesterday.

There is only one thing you need to do now and that is to rebalance. Buy or sell what you need to reweight every position to its appropriate 5% or 10% weighting. Rebalancing is one of the only free lunches out there and always adds performance over time. You should follow the rules assiduously.

Despite the seismic changes that have taken place in the global economy over the past nine months, I only need to make minor changes to the portfolio, which I have highlighted below.

To download the entire new portfolio in an excel spreadsheet, please go to www.madhedgefundtrader.com, log in, go “My Account”, then “Global Trading Dispatch”,then click on the “Long Term Portfolio” button.

Changes

I am cutting back my weighting in biotech from 25% to 20% because Celgene (CELG) was taken over by Bristol Myers (BMY) at a 110% profit compared to our original cost. We also earned a spectacular 145% gain on Crisper Therapeutics (CRSP). I’m keeping it because I believe it has more to run.

My 30% weighting in technology also gets pared back to 20% because virtually all of my names have doubled or more. These have been in a sideways correction for the past six months but are still an important part of any barbell portfolio. So, take out Facebook (FB) and ****** (PYPL) and keep the rest.

I am increasing my weighting in banks from 10% to 20%. Interest rates are finally starting to rise, setting up a perfect storm in favor of bank earnings. Loan default rates are falling. Banks are overcapitalized, thanks to Dodd-Frank. And because of the trillions in government stimulus loans they are disbursing, they are now the most subsidized sector of the economy. So, add in Morgan Stanley (MS) and Goldman Sachs (GS), which will profit enormously from a continuing bull market in stocks.

Along the same vein, I am committing 10% of my portfolio to a short position in the United States Treasury Bond Fund (TLT) as I think bonds are about to go to hell in a handbasket. I rant on this sector on an almost daily basis, so go read Global Trading Dispatch.

I am keeping my 10% international exposure in Chinese Internet giant Alibaba (BABA) and the iShares MSCI Emerging Market ETF (EEM). The Biden administration will most likely dial back the recent vociferous anti-Chinese stance, setting these names on fire.

I am also keeping my foreign currency exposure unchanged, maintaining a double long in the Australian dollar (FXA). The Aussie has been the best performing currency against the US dollar and that should continue.

Australia will be a leveraged beneficiary of the synchronized global economic recovery, both through strong commodity prices and gold which has already started to rise, and the post-pandemic return of Chinese tourism and investment. I argue that the Aussie will eventually make it to parity with the US dollar, or 1:1.

As for precious metals, I’m baling on my 10% holding in gold (GLD), which delivered a nice 20% gain in 2020. From here, it is having trouble keeping up with other alternative assets, like Bitcoin, and there are better fish to fry.

Yes, in this liquidity-driven global bull market, a 20% return is just not enough to keep my interest. Instead, I add a 5% weighting in the higher beta and more volatile iShares Silver Trust (SLV), which has far wider industrial uses in solar panels and electric vehicles.

As for energy, I will keep my weighting at zero. Never confuse “gone down a lot” with “cheap”. I think the bankruptcies have only just started and will stretch on for a decade. Thanks to hyper-accelerating technology, the adoption of electric cars, and less movement overall in the new economy, energy is about to become free. You are looking at the next buggy whip industry.

My ten-year assumption for the US and the global economy remains the same. I’m looking at 3%-5% a year growth for the next decade.

When we come out the other side of this, we will be perfectly poised to launch into my new American Golden Age, or the next Roaring Twenties. With interest rates still at zero, oil cheap, there will be no reason not to. The Dow Average will rise by 400% or more in the coming decade. The America coming out the other side of the pandemic will be far more efficient, productive, and profitable than the old.

You won’t believe what’s coming your way!

I hope you find this useful and I’ll be sending out another update in six months so you can rebalance once again.

Stay healthy.

John Thomas
CEO & Publisher
The Diary of a Mad Hedge Fund Trader
[/FONT]
[FONT=Arial, Helvetica, sans-serif][/FONT][FONT=Arial, Helvetica, sans-serif] [/FONT]
[FONT=Arial, Helvetica, sans-serif][/FONT]
[FONT=Arial, Helvetica, sans-serif]
long-term-portfolio.png
[/FONT]​
[FONT=Arial, Helvetica, sans-serif][/FONT][FONT=Arial, Helvetica, sans-serif] [/FONT]
[FONT=Arial, Helvetica, sans-serif][/FONT]
[FONT=Arial, Helvetica, sans-serif]
aapl-feb2.png
[/FONT]​
[FONT=Arial, Helvetica, sans-serif][/FONT][FONT=Arial, Helvetica, sans-serif] [/FONT]
[FONT=Arial, Helvetica, sans-serif][/FONT]
[FONT=Arial, Helvetica, sans-serif]
crsp-feb2.png
[/FONT]​
[FONT=Arial, Helvetica, sans-serif][/FONT][FONT=Arial, Helvetica, sans-serif] [/FONT]
[FONT=Arial, Helvetica, sans-serif][/FONT]
[FONT=Arial, Helvetica, sans-serif]
jpm-feb2.png
[/FONT]​
[FONT=Arial, Helvetica, sans-serif][/FONT][FONT=Arial, Helvetica, sans-serif] [/FONT]
[FONT=Arial, Helvetica, sans-serif][/FONT]
[FONT=Arial, Helvetica, sans-serif]
fxa-feb2.png
[/FONT]​
[FONT=Arial, Helvetica, sans-serif][/FONT][FONT=Arial, Helvetica, sans-serif] [/FONT]
[FONT=Arial, Helvetica, sans-serif][/FONT]
[FONT=Arial, Helvetica, sans-serif]
fcx-feb2.png
[/FONT]​
[FONT=Arial, Helvetica, sans-serif][/FONT][FONT=Arial, Helvetica, sans-serif] [/FONT]
[FONT=Arial, Helvetica, sans-serif][/FONT]
[FONT=Arial, Helvetica, sans-serif]
john-headshot-e1475724748969.png
[/FONT]


Quote of the Day“If politicians delivered everything they promised, there would be absolutely no reason to go to Heaven,” said American humorist Will Rodgers.

will-rogers.png



This is not a solicitation to buy or sell securities
The Mad Hedge Fund Trader is not an Investment advisor
For full disclosures click here at:

http://www.madhedgefundtrader.com/disclosures

The "Diary of a Mad Hedge Fund Trader"(TM)
and the "Mad Hedge Fund Trader" (TM)
are protected by the United States Patent and Trademark Office
The "Diary of the Mad Hedge Fund Trader" (C)
is protected by the United States Copyright Office


Futures trading involves a high degree of risk and may not be suitable for everyone.[FONT=&quot][/FONT]




 

Member
Joined
Dec 13, 2007
Messages
13,108
Tokens
CVM..But another Bio.

This might be the longest trial I've ever seen and it looks like they've taken the long but most favorable path for approval
https://cel-sci.com


Worth checking out.. stellar phase II results
https://scr.zacks.com/News/Press-Re...w-Solution-in-Head--Neck-Cancer-/default.aspx


Phase III has been completed the FDA is analyzing the Data set now.

Looking for another dip before I buy..Found this in a bit of a round about way in doing research on AVDL a few days ago.

If this gets shot down by the FDA it's a 100% loss... with approval 250+ IMO

Don't play this if you can't afford a loss...23.00 and change today
 

Member
Joined
Dec 13, 2007
Messages
13,108
Tokens
Unreal the path this company took...The end point being a % of death is unusual . Good thing here is you'll know pretty quickly if you're a winner or loser as the endpoint was met a few months ago.
I've been reading about the journey here and who's stayed invested..60% institutional and blackrock has been upping it's position ..up 23% recently



The end of the long Multikine development program for CEL-SCI is near!
Multikine has fully enrolled the largest head and neck cancer study ever in 24 countries, including the United States. The last patients were enrolled in September 2016 and our Phase 3 trial is finally coming to an end. Advanced primary head and neck cancer is a large unmet medical need that has only one recommended standard of care. The last FDA approval for advanced primary head and neck cancer was over 50 years ago. We have orphan drug status for this disease. If Multikine is shown to increase survival when added to this standard of care, one could well imagine that Multikine should become part of the new standard of care.

Nine hundred twenty-eight (928) newly diagnosed head and neck cancer patients have been enrolled in this Phase III cancer study and all the patients who have completed treatment continue to be followed for protocol-specific outcomes in accordance with the Study Protocol. The study’s primary endpoint is a 10% increase in overall survival for patients treated with the Multikine treatment regimen plus SOC versus those who receive SOC only. The determination if the study’s primary end point has been met will occur when there are a total of 298 deaths in those two groups.
* Multikine is the trademark that CEL-SCI has registered for this investigational therapy, and this proprietary name is subject to FDA review in connection with our future anticipated regulatory submission for approval. Multikine has not been licensed or approved for sale, barter or exchange by the FDA or by any other regulatory agency. Similarly, its safety or efficacy has not been established for any use. Moreover, no definitive conclusions can be drawn from the early-phase, clinical-trials data summarized on this page or elsewhere on this website involving the investigational therapy Multikine (Leukocyte Interleukin, Injection). Further research is required, and early-phase clinical trial results must be confirmed in the well-controlled, Phase III clinical trial of this investigational therapy that is currently in progress.
 

Member
Joined
Dec 13, 2007
Messages
13,108
Tokens
Buying ATOS this AM early.


LISTEN TO TODAY'S PODCAST AVAILABLE AT 8AM ON:
Top News
shutterstock_1399561361.jpg
Shutterstock​
Amazon (NASDAQ:AMZN) posted record revenues of more than $125B for the fourth quarter after the closing bell on Tuesday, up a whopping 44% Y/Y on holiday and pandemic-driven demand, but the biggest news wasn't the ringing of the register. CEO Jeff Bezos said he would step aside later this year, though he would remain engaged at Amazon as executive chairman. Andy Jassy, the head of the company's cloud division, will take the helm of the e-commerce giant in the third quarter.

Although Bezos' departure was announced last year, Amazon consumer boss Jeff Wilke officially made his exit last month and was considered the number two at the company. Jassy is also an Amazon veteran (he's been with Bezos since 1997) and was the architect of Amazon Web Services, which is how Amazon makes most of its money. In the most recent quarter, AWS had net sales of $12.7B with an operating income of $3.6B, more than half of the firm's overall operating income. AWS also has a market share of around 34%, according to Synergy Research Group.

Why is Bezos taking a back seat? "Being the CEO of Amazon is a deep responsibility, and it's consuming,” he declared, saying it was time to focus on some of his passion projects and philanthropic ventures. Those include The Washington Post newspaper and private space company Blue Origin (BORGN), as well as his Day One Fund and the Bezos Earth Fund. Bezos, aged 57, founded Amazon from his garage in Seattle in 1994, eventually expanding the company to dominate industries like online retail, groceries, streaming, cloud computing and artificial intelligence.

Outlook: Trading volatility was seen AH, before Amazon shares ended the session slightly lower, as investors digested the news. Amazon also said sales in Q1 would be between $100B-$106B, a slowdown from the fourth quarter but an increase of between 33% and 40% from a year earlier, and expects coronavirus-related costs to decelerate after several months of heavy investments. Amazon also revealed the design of its 350-foot-tall "HQ2" in Virginia, which features spiraling outdoor walkways and was dubbed the Helix. (252 comments)
Stocks
U.S. stock index futures are moving into the green for a third day, powered by strong tech earnings, stimulus progress and a broader vaccine rollout. Nasdaq is leading the pack, with contracts linked to the index ahead by 0.7%, on strong quarterly results from Amazon and Google. While CEO Jeff Bezos said he would step down, leading AMZN shares to decline modestly, Alphabet (GOOG, GOOGL) soared over 7% AH. The tech giant blew through forecasts with an ad spending recovery, and broke out operating income from its cloud business for the first time, with a loss that showed the business is still in investment mode.

Other happenings: The White House confirmed plans to hike weekly vaccine supplies to 11.5M doses, distributing doses directly to up to 40,000 pharmacies. Over in the Senate, the chamber voted 50 to 49 in a straight party-line decision to begin the budget reconciliation process, which would open the door for Democrats to push through the COVID rescue package on their own. The move would avoid the filibuster that requires 60 votes for most legislation, although President Biden did meet with a group of Republican senators on Monday and expressed willingness to agree to some modifications.

Funds also appear to be flowing back into traditional names, with meme stocks losing a total of $167B in market capitalization following another brutal selloff on Tuesday. Things aren't looking better premarket: GameStop (NYSE:GME) -5%; AMC Entertainment (NYSE:AMC)-5%; BlackBerry (NYSE:BB) -4%.

What's next for the WSB/Reddit crowd? Barstool Sports founder Dave Portnoy pulled out of the trade yesterday with a $700K loss, though others like Mark Cuban aren't convinced the action has run its course. What seems to be the biggest problem is the collective unity needed to band together retail traders on an anonymous platform. Once rumors get out, users become suspicious of each other or bail on a stock, a trade can break down within a session. (16 comments)
TRENDING
The best stocks of 2020 all had one thing in common: Each is transforming its industry and changing the way we do business - or live our lives. This monumental shift is just getting started! And it’s giving OTHER companies all the runway they need to break out in 2021. Get a full report from The Data Driven Investor - our #1 stock-picker!

Learn more »
Regulation
Although the "meme stock" trade continues to unwind, discussions over market volatility continue to ensue. Treasury Secretary Janet Yellen has called a meeting with the SEC, the Federal Reserve Board, the Federal Reserve Bank of New York and the Commodity Futures Trading Commission to address the recent market frenzy involving GameStop (NYSE:GME) and Robinhood. This comes after the SEC said it was investigating "manipulative trading activity," as well as actions taken to "unduly inhibit the ability to trade certain securities."

Fine print: Yellen has requested an ethics waiver to hold the meeting after receiving more than $700,000 in speaking fees from Citadel Advisors, the financial empire run by Ken Griffin. Griffin also runs a hedge fund and controls Citadel Securities, a market maker that executes trades for Robinhood.

What could happen? Likely nothing, but if the SEC were to act, it could pursue a series of rules, ranging from short interest caps to taxing short-term bets, according to BofA analyst Michael Carrier. The commission may also move to review payment for order flows (PFOF) and pursue social media oversight to ward off potential market manipulation. Jefferies analyst Daniel Fannon meanwhile thinks the SEC could explore greater investor education around derivatives and risk management or increase costs for leverage services.

This is all taking place while the SEC operates under temporary leadership. The eventual confirmation of Gary Gensler, President Biden's pick for the agency, is a virtual certainty, but it could take weeks or months for the Senate to approve him. Right now, the chamber is focusing on Biden's cabinet-level nominations, coronavirus relief and a possible impeachment trial for President Trump. (88 comments)
Outlook
A topic that has gotten lots of attention on Wall Street over the last few days is a requirement that stocks be physically deposited in an account within two days of making a transaction - a process known as "T+2." During that time, brokers have to post collateral to the Depository Trust & Clearing Corp. because equity prices can fluctuate over those 48 hours, and the lag can make sure everything turns out alright. Some buyers are also using margin and sellers can be tapping borrowed shares, so the requirement could help prevent brokers from getting burned before the transactions settle.

Backdrop: For many years, markets operated on a "T+5" settlement cycle, when security transactions were done manually. In the 1990s, the SEC shortened the settlement cycle to three business days, which reduced the amount of money that needed to be collected at any given time. It was only in 2017 that the commission moved to T+2, calling the previous standard an outdated "settlement cycle" due to improvements in technology, emerging new products and growing trading volumes.

Latest argument: Given our current lightning-fast systems, many market participants say two days is too long to settle trades. "Moving the industry closer to T+1 settlement is good for everyone because the less risk we maintain in the system, the better off everyone is," said Shane Swanson, former director of equity market structure at Citadel Securities. Some are even calling for instant settlement, like Robinhood (RBNHD) CEO Vlad Tenev, who had to put up some big funds this week to cover the trading frenzy on his platform.

"There is no reason why the greatest financial system the world has ever seen cannot settle trades in real time. Doing so would greatly mitigate the risk that such processing poses," Tenev wrote in a blog post. "Technology is the answer, not the oft-cited impediment. We believe it is important for all relevant stakeholders to convene in the near term to discuss the urgency and necessity of this issue."
What else is happening...
Mario Draghi may be Italy's next prime minister.

SpaceX (SPACE) test flight ends with fireball on landing.

Kia Motors shares soar on EV tie-up with Apple (NASDAQ:AAPL) - Reuters.

Reports suggest Kraft Heinz (NASDAQ:KHC) may sell Planters for $3B.​
Today's Markets
In Asia, Japan +1%. Hong Kong +0.2%. China -0.5%. India +0.9%.
In Europe, at midday, London +0.1%. Paris +0.3%. Frankfurt +0.7%.
Futures at 6:20, Dow +0.1%. S&P +0.4%. Nasdaq +0.7%. Crude +0.6% to $55.08. Gold +0.1% at $1836. Bitcoin +3.2% to $36041.
Ten-year Treasury Yield +1 bps to 1.11%​
Today's Economic Calendar


 

Member
Joined
Dec 13, 2007
Messages
13,108
Tokens
I love a halt in a phase II..this one didn't make the news cycle early today as it was halted late last night.
Taking a quick dip for the next few days.



Atossa Therapeutics’ Phase 2 Endoxifen Breast Cancer Study Produces Substantially Positive Results Allowing Study to be Halted Early

ATOS

    • +10.3607%

      SEATTLE, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, today announces that based on substantially positive results achieved with the patients enrolled to date in its Australian open-label Phase 2 clinical study of oral Endoxifen administered in the “window of opportunity” between diagnosis of breast cancer and surgery, Atossa has halted the study and is accelerating its Endoxifen program in the United States.

      “It is a welcome event to halt an ongoing clinical trial because the results are so overwhelmingly positive,” commented Steven Quay, M.D., Ph.D., Atossa’s President and Chief Executive Officer. “Data from the first six patients in our Australian Phase 2 window of opportunity study shows a 74% average reduction in Ki-67, which is a common measure of tumor cell activity, and that at the time of surgery all patients had Ki-67 levels lower than 25%, which is an important threshold to improve long-term survival as identified in studies by others. We believe that additional enrollment will not alter these positive results so we are terminating the study early. This saves at least a year on the development time line allowing us to accelerate clinical development in the Unites States. We look forward to reporting final data from all patients in the study and sharing our continued progress in the development of oral Endoxifen.”
      The study enrolled seven newly-diagnosed patients with ER+ and human epidermal growth factor receptor 2 negative (HER2-) stage 1 or 2 invasive breast cancer, requiring mastectomy or lumpectomy. Patients received Atossa’s proprietary oral Endoxifen for at least 14 days from the time of diagnosis up to the day of surgery. The primary endpoint is to determine if the administration of oral Endoxifen reduces the tumor activity as measured by Ki-67. The secondary endpoints are safety and tolerability and assessment of the study drug on expression levels of both estrogen and progesterone receptors. The Phase 2 study was conducted on behalf of Atossa by Avance Clinical, a leading Australian CRO.

      The American Cancer Society (ACS) estimates that in 2020, 276,480 women will be diagnosed with breast cancer in the U.S. Every two minutes an American woman is diagnosed with breast cancer and 42,170 die each year.
      Atossa is evaluating a number of potential clinical benefits and potential indications for its oral Endoxifen in the window of opportunity setting. These may include avoidance of surgery in some patients, such as older and/or frail patients, allowing for breast conservation surgery, and use of Endoxifen in place of other neoadjuvant therapies such as chemotherapy, aromatase inhibitors and other endocrine therapies like tamoxifen.
      About Atossa Therapeutics
      Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19. For more information, please visit www.atossatherapeutics.com.
      Forward-Looking Statements Disclaimer Statement
      Forward-looking statements in this press release, which Atossa undertakes no obligation to update, are subject to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results, including, without limitation, statements regarding the satisfaction of closing conditions relating to the offering and the anticipated use of proceeds from the offering, the risks and uncertainties associated with any variation between interim and final clinical results, actions and inactions by the FDA, the outcome or timing of regulatory approvals needed by Atossa including those needed to commence studies of AT-H201, AT-301 and Endoxifen, lower than anticipated rate of patient enrollment, estimated market size of drugs under development, the safety and efficacy of Atossa’s products, performance of clinical research organizations and investigators, obstacles resulting from proprietary rights held by others such as patent rights, whether reduction in Ki-67 or any other result from a neoadjuvant study is an approvable endpoint for oral Endoxifen, and other risks detailed from time to time in Atossa’s filings with the Securities and Exchange Commission, including without limitation its periodic reports on Form 10-K and 10-Q, each as amended and supplemented from time to time.
      Company Contact:
      Atossa Therapeutics, Inc.
      Kyle Guse, CFO and General Counsel
      Office: 866 893-4927
      kyle.guse@atossainc.com
      Investor Relations Contact:
      Core IR
      Office:(516) 222-2560
      ir@atossainc.com












 

Member
Joined
Oct 12, 2008
Messages
10,180
Tokens
u a chartist Boz?

from my lens ATOS is forming a J-hook pattern. IF it was to take out $3.75, holy molly you could have a runner , just sayin'..hopefully a strong close, today's candle just forming of course

nice call

qqq- double top possibly.....the day is young
 

Member
Joined
Dec 13, 2007
Messages
13,108
Tokens
u a chartist Boz?

from my lens ATOS is forming a J-hook pattern. IF it was to take out $3.75, holy molly you could have a runner , just sayin'..hopefully a strong close, today's candle just forming of course

nice call

qqq- double top possibly.....the day is young


Not as I should be...I like data with these Bio's.
I can read simple candles but the "J" as far as I know is something many seem to smoke in Oregon given the thousands of weed shops
Doubt i'll hold past tomorrow

Your Chart analytics is always welcome


The one I'm really hot on is CVM but want it to find the old trench it was in before I move on it.
 

Member
Joined
Dec 13, 2007
Messages
13,108
Tokens
u a chartist Boz?

from my lens ATOS is forming a J-hook pattern. IF it was to take out $3.75, holy molly you could have a runner , just sayin'..hopefully a strong close, today's candle just forming of course

nice call

qqq- double top possibly.....the day is young

Looking good in the AF..5 mil traded up to 3.80 ...short interest has to be nervous.

This I didn't know..
J hook

https://hitandruncandlesticks.com/bullish-j-hook/

Thanks!
 

Member
Joined
Feb 28, 2005
Messages
8,810
Tokens
Good call on ATOS. I missed your post today - I was in the office at can't log into this site...dammit!
 

Member
Joined
Dec 13, 2007
Messages
13,108
Tokens
Man , I miss my job..sorta CB
Aggressive this AM
ATOS 4.63 in the Pre
 

Member
Joined
Feb 28, 2005
Messages
8,810
Tokens
Man , I miss my job..sorta CB
Aggressive this AM
ATOS 4.63 in the Pre

I only have to go in once or twice a week, which I'm fine with (at the Treasury building). I'm waiting until late March or April to ask them if I can go full-time telework (so we can move back to Florida).

Looks like you found a winner w/ ATOS. CTXR did well yesterday, btw.
 

Member
Joined
Dec 13, 2007
Messages
13,108
Tokens
I only have to go in once or twice a week, which I'm fine with (at the Treasury building). I'm waiting until late March or April to ask them if I can go full-time telework (so we can move back to Florida).

Looks like you found a winner w/ ATOS. CTXR did well yesterday, btw.
I did buy a small amount of CTXR , yesterday was a bit nuts...I'd like to see it come back down today.
CVM is the one I want but it's got the most risk and the most upside X10 at the least..Phase II was a small sample size but the results were good... the size make makes nervous.
Head and Neck Cancer care is CVM's driver. Trading around 20. yesterday after falling from what looked like a solid 30.dollars
Traded between 15 and 12 for months looking for it to fall back in to that trench..hopefully..The more time that passes the further this will fall...Happens a lot as results get stung out over time with anxious traders.
Some people think results will come this month..I'm thinking end of march or sometime in April but I'm guessing like everyone else..No telling with the FDA during Covid days.

LLNW earnings coming up I'm thinking I might bail if I can get back to Par....They have bad pricing problems..In old terms..They are being bent over a barrel and fucked by the huge costumers they have..Fear of losing them I'd guess.

Time will turn LLNW but I have others I want to get in now or up positions.
 

Member
Joined
Dec 13, 2007
Messages
13,108
Tokens
LISTEN TO TODAY'S PODCAST AVAILABLE AT 8AM ON:
Top News
shutterstock_1689084883_1_.jpg
Shutterstock​
The Biden administration is moving full speed ahead on a $1.9T coronavirus economic relief plan after House Democrats adopted a budget resolution that would enable a bill to pass with a simple majority (VP Kamala Harris would cast a tie-breaking vote). Despite a public debt load of $27T, the consensus stance from the Democratic camp is not making the case for fiscal restraint at this stage in the recovery. Stocks have been buoyed by the stimulus efforts in recent days, with the major averages set to open in the green for the fourth straight session.

New thinking in economics? The idea here is that with interest rates at essentially zero, any growth seen from the measures will pay back the borrowing, while it would cost the economy more if the government does not go through with the spending. Economic policymakers from Treasury Secretary Janet Yellen to Fed Chair Jay Powell have also urged the administration to "act big," believing in the long run that the "benefits will far outweigh the costs." Republicans meanwhile want something more targeted and are seeking to ensure the funding from Congress' most recent stimulus package is fully spent first. Their bill also doesn't include state and local aid, paid sick leave, a $15 minimum wage and expansion to the child tax credit.

Flashback: Biden likely remembers President Obama's first term in office, when he spent much time trying to secure GOP support for additional stimulus measures during the global financial crisis. Obama pushed for a $1T stimulus package, or roughly 25% bigger than the record-setting legislation that ultimately got through Congress, though this time around, the Republican proposal is less than a third of Biden's planned $1.9T proposal.

While President Biden has signaled some areas of compromise, and met with GOP senators over a smaller $600B offer, he won't ditch an overall package for the sake of bipartisanship. "Time is a luxury our country does not have," Senate Majority Leader Chuck Schumer said before moving forward with the budget process. Some concessions may be seen with stimulus checks, and Biden has indicated the direct payments could be sent to a smaller group of Americans. Previous checks were given to citizens making under $75,000 per year, but that is now likely to be reduced to $50,000, which would cut the total price tag of the COVID aid bill.
Covid
Given the scarce supplies across the world, a new vaccine trial being launched in the U.K. will explore whether using different coronavirus jabs works for first and second doses. The trial, led by the University of Oxford and run by the National Immunisation Schedule Evaluation Consortium, will last for 13 months and recruit 820 participants over the age of 50. It's being backed by £7M of government funding from the Vaccine Taskforce, which was set up by the U.K. last April to research and produce a coronavirus vaccine.

Quote: "If we do show that these vaccines can be used interchangeably in the same schedule this will greatly increase the flexibility of vaccine delivery, and could provide clues as to how to increase the breadth of protection against new virus strains," said Matthew Snape, chief investigator on the trial and associate professor in Paediatrics and Vaccinology at the University of Oxford.

The trial will specifically examine the immune responses of an initial dose of Pfizer's (NYSE:PFE) vaccine followed by a booster of AstraZeneca's (NASDAQ:AZN) - and vice versa - with intervals of 4 and 12 weeks. Researchers will measure antibody and T-cell responses, as well as monitor for any unexpected side effects.

Go deeper: The biggest advantages of the AstraZeneca/Oxford shot are price and storage. It does not need to be kept at ultra-low temperatures and costs about $4 a dose, compared to the $20 per vial from Pfizer and $33 for Moderna's (MRNA) jab. A vaccine milestone was also seen yesterday as the number of global inoculations surpassed the total number of confirmed cases of COVID-19.
TRENDING
The best stocks of 2020 all had one thing in common: Each is transforming its industry and changing the way we do business - or live our lives. This monumental shift is just getting started! And it’s giving OTHER companies all the runway they need to break out in 2021. Get a full report from The Data Driven Investor - our #1 stock-picker!

Learn more »
Automotive
There's a lot of rumblings in the auto sector, especially surrounding EVs and a chip shortage that's hitting the industry. Strong demand across the U.S. and China continue to be received favorably by investors, triggering a broad rally yesterday across the EV landscape. According to data from Edmunds, EV sales in in the U.S. climbed 4% Y/Y in 2020, outperforming the auto market (down 15% Y/Y), mostly from the introduction of the Model Y. Tesla (NASDAQ:TSLA) also extended its sector domination with 79% of all BEV (battery electric vehicle) sales. Other happenings:

Apple Car - Reports suggest the company is close to finalizing a deal with Hyundai-Kia to manufacture an Apple-branded autonomous electric vehicle at the Kia assembly plant in West Point, Georgia. The vehicle would go into production in 2024 and would be designed to operate without a driver and focused on the last mile (delivery, robotaxis?). "Smartphones are a $500B annual TAM (total addressable market). Apple has about one-third of this market. The mobility market is $10T. So Apple would only need a 2% share of this market to be the size of their iPhone business," wrote Morgan Stanley analyst Katy Huberty. (33 comments)

Rivian - A year and a half after announcing it would buy 100K Rivian electric trucks to reduce its carbon footprint, Amazon (NASDAQ:AMZN) has begun using prototype vehicles for deliveries in Los Angeles. The e-commerce giant plans to expand its testing to 15 more cities this year as part of a broad goal to be net zero carbon emissions across its operations by 2040. Rivian is meanwhile looking to start production by the end of this year and shake up the market in 2022 and beyond. (38 comments)

Chip crunch - Ford (NYSE:F), Toyota (NYSE:TM) and Stellantis (NYSE:STLA) have already idled some plants due to a shortage of semiconductors, and General Motors (NYSE:GM) is joining them in taking production offline for a week. The downtime was scheduled at four assembly plants, including three in North America, though GM hasn't revealed how much volume it expects to lose or which supplier was directly affected. "Despite our mitigation efforts, the semiconductor shortage will impact GM production in 2021," spokesman David Barnas said in a statement. (33 comments)
Tech
Australia's Prime Minister Scott Morrison has finally spoken with Alphabet (GOOG, GOOGL) CEO Sundar Pichai amid friction over the country's media bill that was introduced in December. The legislation would force digital platform companies to pay for news content in feeds or search results, meaning Google would have to shell out cash to local media outlets and publishers for linking to their content. In response, Google has threatened to shut its search engine in Australia and has been lobbying strongly against the proposal.

Transcript from the call: "I thought it was a constructive meeting," said Morrison. "I have been able to send them the best possible signals that should give them a great encouragement to engage with the process and we discussed some of the specifics of elements of the code. But at the end of the day, they understand that Australia sets the rules for how these things operate. And I was very clear about how I saw this playing out."

If the law were to pass, Facebook (NASDAQ:FB) has also threatened to stop allowing Australians to share local and international news on the social network and Instagram. "The proposed law is unprecedented in its reach... and would force Facebook to pay news organizations for content that the publishers voluntarily place on our platforms and at a price that ignores the financial value we bring publishers," the company last said in a blog post.

Go deeper: Standing to gain from the fallout, Microsoft (NASDAQ:MSFT) has slammed Google for threatening to leave the country and offered to fill the gap left by the exit with its own search engine - Bing. "We believe that the current legislative proposal represents a fundamental step towards a more level playing field and a fairer digital ecosystem for consumers, business, and society," Microsoft President Brad Smith declared. To put it in perspective, Google has more than 94% of the search market in Australia, while Bing has less than 4%. (13 comments)
What else is happening...
Pot play: Jazz (NASDAQ:JAZZ) to acquire GW Pharma (NASDAQ:GWPH) for $7.2B.

Shell (RDS.A, RDS.B) raises dividend despite sharp profit drop.

Incoming Amazon (NASDAQ:AMZN) CEO set to beef up presence in videogames.

Google (GOOG, GOOGL) seeks FAA approval to test fire-fighting drones.​
Wednesday's Key Earnings
eBay (NASDAQ:EBAY) +10.3% AH on Q4 beats, strong guidance.
****** (NASDAQ:PYPL) +5.1% AH doubling down on crypto.
Qualcomm (NASDAQ:QCOM) -8% AH as sales came up short.​
Today's Markets
In Asia, Japan -1.1%. Hong Kong -0.7%. China -0.4%. India +0.7%.
In Europe, at midday, London +0.1%. Paris +0.5%. Frankfurt +0.5%.
Futures at 6:20, Dow +0.1%. S&P +0.2%. Nasdaq +0.4%. Crude +0.8% to $56.16. Gold -1.3% at $1811.60. Bitcoin +5% to $37845.
Ten-year Treasury Yield flat at 1.13%​
Today's Economic Calendar


 

Member
Joined
Dec 13, 2007
Messages
13,108
Tokens
CB going to Mt Bachelor Monday for a few days..
It's a great deal..lodging is off mountain cheap in Sunriver 20 mIles from the slopes.We got a house with hot tub and great reviews for 120 a night.
Lift tickets are reasonable and the snow has been great this year. Plus it's a super cool layout..You can ski the main Mountain 360 degrees with lots of blacks


Great Map
https://www.mtbachelor.com/the-mountain/maps/winter-lift-trail-map
 

Forum statistics

Threads
1,118,068
Messages
13,551,086
Members
100,562
Latest member
faul
The RX is the sports betting industry's leading information portal for bonuses, picks, and sportsbook reviews. Find the best deals offered by a sportsbook in your state and browse our free picks section.FacebookTwitterInstagramContact Usforum@therx.com